Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01268072 · ClinicalTrials.gov registry record
A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease
A clinical trial, sponsored by MedImmune.
- Terminated
- Registry status
- 61
- Enrollment target
NCT01268072 is a clinical trial that was terminated before completion, run by MedImmune. The registered enrollment target is 61 participants.
The verdict
NCT01268072 was terminated before completion, sponsored by MedImmune.
- TERMINATED
- Registry status
- 61 participants
- Enrollment target
Study Summary
The primary objective of this study is to identify biomarkers that can be used for evaluation of efficacy in subjects presenting with AECOPD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2011-02 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01268072
The ClinicalTrials.gov registry entry for NCT01268072 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01268072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01268072 about?
NCT01268072 is a clinical study titled "A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease". The primary objective of this study is to identify biomarkers that can be used for evaluation of efficacy in subjects presenting with AECOPD
What is the current status of trial NCT01268072?
This trial is currently terminated. The enrollment target is 61 participants. The study started on 2011-02. Estimated completion is 2013-01.
Who is sponsoring clinical trial NCT01268072?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.